Celanese places Anne Noonan on two board committees
Celanese Corporation named Anne P. Noonan to the Compensation and Management Development Committee and the Nominating and Corporate Governance Committee. The board took this step on October 15, 2026, making the roles effective right away. The company disclosed these moves in an amendment to its Current Report on Form 8-K, submitted to the U.S. Securities and Exchange Commission on October 20, 2026. This filing updates information from an earlier Form 8-K filed on April 20, 2026. That prior report noted the election of Ms. Noonan to the Celanese Board of Directors. At that earlier time, the board had not decided which specific committees she would join. The new appointment settles that open question by assigning her to both governance bodies at once. Ashley B. Duffie, Senior Vice President, General Counsel and Corporate Secretary, signed the amendment for Celanese Corporation. The company’s common stock, valued at $0.0001 per share, trades under the symbol CE on the New York Stock Exchange. The registrant also lists four senior note series on the exchange: 2.125% Senior Notes due 2027 (CE/27), 0.625% Senior Notes due 2028 (CE/28), 5.337% Senior Notes due 2029 (CE/29A), and 5.000% Senior Notes due 2031 (CE/31). Celanese Corporation is incorporated in Delaware and keeps its principal executive offices at 222 West Las Colinas Blvd., Suite 900N, Irving, TX 75039. The company’s Commission File Number is 001-32410 and its IRS Employer Identification Number is 98-0420726. The amendment serves as Amendment No. 1 to the original report dated April 16, 2026, which established the earliest event date for the filing cycle.
Celanese Corporation named Anne P. Noonan to the Compensation and Management Development Committee and the Nominating and Corporate Governance Committee. The board took this step on October 15, 2026, making the roles effective right away. The company disclosed these moves in an amendment to its Current Report on Form 8-K, submitted to the U.S. Securities and Exchange Commission on October 20, 2026. This filing updates information from an earlier Form 8-K filed on April 20, 2026. That prior report noted the election of Ms. Noonan to the Celanese Board of Directors. At that earlier time, the board had not decided which specific committees she would join. The new appointment settles that open question by assigning her to both governance bodies at once. Ashley B. Duffie, Senior Vice President, General Counsel and Corporate Secretary, signed the amendment for Celanese Corporation. The company’s common stock, valued at $0.0001 per share, trades under the symbol CE on the New York Stock Exchange. The registrant also lists four senior note series on the exchange: 2.125% Senior Notes due 2027 (CE/27), 0.625% Senior Notes due 2028 (CE/28), 5.337% Senior Notes due 2029 (CE/29A), and 5.000% Senior Notes due 2031 (CE/31). Celanese Corporation is incorporated in Delaware and keeps its principal executive offices at 222 West Las Colinas Blvd., Suite 900N, Irving, TX 75039. The company’s Commission File Number is 001-32410 and its IRS Employer Identification Number is 98-0420726. The amendment serves as Amendment No. 1 to the original report dated April 16, 2026, which established the earliest event date for the filing cycle.